QUADRANT CAPITAL GROUP LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 6 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
QUADRANT CAPITAL GROUP LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$106,578
+10.7%
2,790
+4.6%
0.01%
+10.0%
Q2 2023$96,235
+143.7%
2,668
+158.0%
0.01%
+150.0%
Q1 2023$39,489
-27.7%
1,034
+7.7%
0.00%
-33.3%
Q4 2022$54,624
+203.5%
960
+111.5%
0.01%
+200.0%
Q3 2022$18,000
-10.0%
454
+0.4%
0.00%
-33.3%
Q2 2022$20,000
+42.9%
452
+25.9%
0.00%
+50.0%
Q1 2022$14,000
+55.6%
359
+56.1%
0.00%
+100.0%
Q4 2021$9,000
+50.0%
230
+46.5%
0.00%0.0%
Q3 2021$6,0000.0%157
+26.6%
0.00%0.0%
Q2 2021$6,000
+20.0%
124
+2.5%
0.00%0.0%
Q1 2021$5,0000.0%121
+12.0%
0.00%0.0%
Q4 2020$5,000
+66.7%
1080.0%0.00%0.0%
Q3 2020$3,0000.0%108
+14.9%
0.00%0.0%
Q2 2020$3,000
-91.7%
94
-95.4%
0.00%
-83.3%
Q1 2020$36,000
+2.9%
2,053
+0.5%
0.01%
+50.0%
Q4 2019$35,000
+483.3%
2,042
+476.8%
0.00%0.0%
Q4 2015$6,0003540.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
SNYDER CAPITAL MANAGEMENT L P 4,324,232$165,185,6623.73%
Steamboat Capital Partners, LLC 196,898$7,521,5042.79%
2Xideas AG 600,799$22,950,5222.54%
BERNZOTT CAPITAL ADVISORS 171,808$6,563,0662.26%
Redwood Investments, LLC 328,459$12,547,1341.70%
Mesirow Institutional Investment Management, Inc. 380,415$14,531,8531.47%
Granite Investment Partners, LLC 856,253$32,708,8651.37%
Penn Capital Management Company, LLC 324,707$12,453,2111.28%
EFG Asset Management (North America) Corp. 137,739$5,262,3191.25%
First Light Asset Management, LLC 313,536$11,977,0751.14%
View complete list of HALOZYME THERAPEUTICS INC shareholders